Humbert M - Search Results

1

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.

Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, McLaughlin VV, Preston IR, Souza R, Waxman AB, Grünig E, Kopeć G, Meyer G, Olsson KM, Rosenkranz S, Xu Y, Miller B, Fowler M, Butler J, Koglin J, de Oliveira Pena J, Humbert M; STELLAR Trial Investigators. Hoeper MM, et al. Among authors: humbert m. N Engl J Med. 2023 Apr 20;388(16):1478-1490. doi: 10.1056/NEJMoa2213558. Epub 2023 Mar 6. N Engl J Med. 2023. PMID: 36877098 Clinical Trial.

2

Treatment of pulmonary arterial hypertension.

Humbert M, Sitbon O, Simonneau G. Humbert M, et al. N Engl J Med. 2004 Sep 30;351(14):1425-36. doi: 10.1056/NEJMra040291. N Engl J Med. 2004. PMID: 15459304 Review. No abstract available.

3

NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypertension.

Souza R, Jardim C, Julio Cesar Fernandes C, Silveira Lapa M, Rabelo R, Humbert M. Souza R, et al. Among authors: humbert m. Respir Med. 2007 Jan;101(1):69-75. doi: 10.1016/j.rmed.2006.04.014. Epub 2006 Jun 14. Respir Med. 2007. PMID: 16781131 Free article.

4

Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm.

Bresser P, Pepke-Zaba J, Jaïs X, Humbert M, Hoeper MM. Bresser P, et al. Among authors: humbert m. Proc Am Thorac Soc. 2006 Sep;3(7):594-600. doi: 10.1513/pats.200605-115LR. Proc Am Thorac Soc. 2006. PMID: 16963540 Review.

5

Endothelin-1/endothelin-3 ratio: a potential prognostic factor of pulmonary arterial hypertension.

Montani D, Souza R, Binkert C, Fischli W, Simonneau G, Clozel M, Humbert M. Montani D, et al. Among authors: humbert m. Chest. 2007 Jan;131(1):101-8. doi: 10.1378/chest.06-0682. Chest. 2007. PMID: 17218562

6

Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.

Cabrol S, Souza R, Jais X, Fadel E, Ali RH, Humbert M, Dartevelle P, Simonneau G, Sitbon O. Cabrol S, et al. Among authors: humbert m. J Heart Lung Transplant. 2007 Apr;26(4):357-62. doi: 10.1016/j.healun.2006.12.014. J Heart Lung Transplant. 2007. PMID: 17403477

7

Pulmonary hypertension: from an orphan disease to a public health problem.

Humbert M, Khaltaev N, Bousquet J, Souza R. Humbert M, et al. Chest. 2007 Aug;132(2):365-7. doi: 10.1378/chest.07-0903. Chest. 2007. PMID: 17699126 No abstract available.

8

Pulmonary arterial hypertension in ANCA-associated vasculitis.

Launay D, Souza R, Guillevin L, Hachulla E, Pouchot J, Simonneau G, Humbert M. Launay D, et al. Among authors: humbert m. Sarcoidosis Vasc Diffuse Lung Dis. 2006 Oct;23(3):223-8. Sarcoidosis Vasc Diffuse Lung Dis. 2006. PMID: 18038922

9

Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.

Sztrymf B, Coulet F, Girerd B, Yaici A, Jais X, Sitbon O, Montani D, Souza R, Simonneau G, Soubrier F, Humbert M. Sztrymf B, et al. Among authors: humbert m. Am J Respir Crit Care Med. 2008 Jun 15;177(12):1377-83. doi: 10.1164/rccm.200712-1807OC. Epub 2008 Mar 20. Am J Respir Crit Care Med. 2008. PMID: 18356561

10

Safety experience with bosentan in 146 children 2-11 years old with pulmonary arterial hypertension: results from the European Postmarketing Surveillance program.

Beghetti M, Hoeper MM, Kiely DG, Carlsen J, Schwierin B, Segal ES, Humbert M. Beghetti M, et al. Among authors: humbert m. Pediatr Res. 2008 Aug;64(2):200-4. doi: 10.1203/PDR.0b013e318179954c. Pediatr Res. 2008. PMID: 18414142

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,370 results

Search Page